Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
Olga Abian, David Ortega-Alarcon, Ana Jimenez-Alesanco, Laura Ceballos-Laita, Sonia Vega, Hugh T Reyburn, Bruno Rizzuti, Adrian Velazquez-Campoy
International Journal of Biological Macromolecules, doi:10.1016/j.ijbiomac.2020.07.235
The global health emergency generated by coronavirus disease 2019 (COVID-19) has prompted the search for preventive and therapeutic treatments for its pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are many potential targets for drug discovery and development to tackle this disease. One of these targets is the main protease, Mpro or 3CLpro, which is highly conserved among coronaviruses. 3CLpro is an essential player in the viral replication cycle, processing the large viral polyproteins and rendering the individual proteins functional. We report a biophysical characterization of the structural stability and the catalytic activity of 3CLpro from SARS-CoV-2, from which a suitable experimental in vitro molecular screening procedure has been designed. By screening of a small chemical library consisting of about 150 compounds, the natural product quercetin was identified as reasonably potent inhibitor of SARS-CoV-2 3CLpro (K i ~7 μM). Quercetin could be shown to interact with 3CLpro using biophysical techniques and bind to the active site in molecular simulations. Quercetin, with well-known pharmacokinetic and ADMET properties, can be considered as a good candidate for further optimization and development, or repositioned for COVID-19 therapeutic treatment.
Declaration of competing interest The authors declare no conflict of interest.
Appendix A. Supplementary data Supplementary data to this article can be found online at https://doi. org/10.1016/j.ijbiomac.2020.07.235 .
References
Abad-Zapatero, Metz, Ligand efficiency indices as guideposts for drug discovery, Drug Discov. Today
Abian, Vega, Sancho, Velazquez-Campoy, Allosteric inhibitors of the NS3 protease from the hepatitis C virus, PLoS One
Adams, Walls, Supporting the Health Care Workforce During the COVID-19 Global Epidemic, JAMA
Andersen, Rambaut, Lipkin, Holmes, Garry, The proximal origin of SARS-CoV-2, Nat. Med
Atzrodt, Maknojia, Mccarthy, Oldfield, Po et al., A guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2, FEBS J,
doi:10.1111/febs.15375Bacha, Barrila, Velazquez-Campoy, Leavitt, Freire, Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro, Biochemistry
Campos, Sharma, Alvira, Ruiz, Ibarra-Molero et al., Engineering protein assemblies with allosteric control via monomer fold-switching, Nat. Commun
Catanzaro, Fagiani, Racchi, Corsini, Govoni et al., Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2, Signal Transduct. Target. Ther
Cimmperman, Baranauskiene, Jachimoviciūte, Jachno, Torresan et al., A quantitative model of thermal stabilization and destabilization of proteins by ligands, Biophys. J
Clarke, An introduction to economic studies, health emergencies, and COVID-19, J. Evid. Based Med
Claveria-Gimeno, Vega, Abian, Velazquez-Campoy, A look at ligand binding thermodynamics in drug discovery, Expert. Opin. Drug Discov
Cremades, Velázquez-Campoy, Martínez-Júlvez, Neira, Pérez-Dorado et al., Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection, ACS Chem. Biol
Ericsson, Hallberg, Detitta, Dekker, Nordlund, Thermofluor-based high-throughput stability optimization of proteins for structural studies, Anal. Biochem
González, Casado, Chueca, Salillas, Velázquez-Campoy et al., Small molecule inhibitors of the response regulator ArsR exhibit bactericidal activity against Helicobacter pylori, Microorganisms
González, Salillas, Velázquez-Campoy, Espinosa Angarica, Fillat et al., Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA, Sci. Rep
Grande, Rizzuti, Occhiuzzi, Ioele, Casacchia et al., Identification by molecular docking of homoisoflavones from Leopoldia comosa as ligands of estrogen receptors, Molecules
Hanwell, Curtis, Lonie, Vandermeersch, Zurek et al., Avogadro: an advanced semantic chemical editor, visualization, and analysis platform, J. Cheminform
Helmy, Fawzy, Elaswad, Sobieh, Kenney et al., The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control, J. Clin. Med
Hidalgo, Latorre, Carrodeguas, Velázquez-Campoy, Sancho et al., Inhibition of pig phosphoenolpyruvate carboxykinase isoenzymes by 3mercaptopicolinic acid and novel inhibitors, PLoS One
Huang, Wang, Li, Ren, Zhao et al., Molecular docking quercetin to 3CLpro. Structure of (a) unliganded 3CLpro (from entry 6Y2E of the PDB
Jo, Kim, Kim, Shin, Kim, Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors, Chem. Biol. Drug Des
Kasimova, Milstein, Freire, The conformational equilibrium of human growth hormone, J Mol Biol
Khan, Zia, Ashraf, Uddin, Ul-Haq, Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach, J. Biomol. Struct. Dyn
Kuo, Chi, Hsu, Liang, Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate, Biochem. Biophys. Res. Commun
Lakowicz, Jayaweera, Szmacinski, Wiczk, Resolution of multicomponent fluorescence emission using frequency-dependent phase angle and modulation spectra, Anal. Chem
Lee, Mittal, Patel, Gatuz, Truong et al., Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsinlike protease using virtual and high-throughput screenings, Bioorg. Med. Chem
Morris, Goodsell, Halliday, Huey, Hart et al., Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, J. Comput. Chem
Morse, Lalonde, Xu, Liu, Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV, Chembiochem. Eur. J. Chem. Biol
Muramatsu, Kim, Nishii, Terada, Shirouzu et al., Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3Clike protease (SARS-CoV 3CLpro) from its polyproteins, FEBS J
Neira, Bintz, Arruebo, Rizzuti, Bonacci et al., Identification of a drug targeting an intrinsically disordered protein involved in pancreatic adenocarcinoma, Sci. Rep
Pantoliano, Petrella, Kwasnoski, Lobanov, Myslik et al., High-density miniaturized thermal shift assays as a general strategy for drug discovery, J. Biomol. Screen
Pey, Ying, Cremades, Velazquez-Campoy, Scherer et al., Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria, J. Clin. Invest
Pirrone, Thakkar, Jacobson, Wigdahl, Krebs, Combinatorial approaches to the prevention and treatment of HIV-1 infection, Antimicrob. Agents Chemother
Pushpakom, Iorio, Eyers, Escott, Hopper et al., Drug repurposing: progress, challenges and recommendations, Nat. Rev. Drug Discov
Renu, Prasanna, Valsala Gopalakrishnan, Coronaviruses pathogenesis, comorbidities and multi-organ damage -a review, Life Sci
Sanchez-Ruiz, Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry, Biophys. J
Santofimia-Castano, Xia, Lan, Zhou, Huang et al., Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis, J. Clin. Invest
Shi, Wei, Song, Dissection study on the severe acute respiratory syndrome 3Clike protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors, J. Biol. Chem
Shriver, Edmondson, Defining the stability of multimeric proteins, Methods Mol. Biol
Tay, Poh, Rénia, Macary, Ng, The trinity of COVID-19: immunity, inflammation and intervention, Nat. Rev. Immunol
Trott, Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem
Velazquez-Campoy, Sancho, Abian, Vega, Biophysical screening for identifying pharmacological chaperones and inhibitors against conformational and infectious diseases, Curr. Drug Targets
Villanueva, Romero-Tamayo, Laplaza, Martínez-Olivan, Velázquez-Campoy et al., Redox-and ligand binding-dependent conformational ensembles in the human apoptosis-inducing factor regulate its pro-life and cell death functions, Antioxid. Redox Signal
Wang, Jiang, Gao, Jin, Wang et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Ward, Holdgate, Isothermal titration calorimetry in drug discovery, Prog. Med. Chem
Wu, Wang, Zeng, Huang, Xu et al., Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus, Virus Res
Yang, Yang, Ding, Liu, Lou et al., The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor, Proc. Natl. Acad. Sci
Zhang, Lin, Kusov, Nian, Ma et al., α-Ketoamides as broadspectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment, J. Med. Chem
Zhang, Lin, Sun, Curth, Drosten et al., Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science
Zhang, Zhong, Xue, Kang, Ren et al., Threedimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease, Protein Cell
Zhu, Zhang, Wang, Li, Yang et al., A novel coronavirus from patients with pneumonia in China, N. Engl. J. Med
DOI record:
{
"DOI": "10.1016/j.ijbiomac.2020.07.235",
"ISSN": [
"0141-8130"
],
"URL": "http://dx.doi.org/10.1016/j.ijbiomac.2020.07.235",
"alternative-id": [
"S0141813020339970"
],
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "International Journal of Biological Macromolecules"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.ijbiomac.2020.07.235"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2020 Elsevier B.V. All rights reserved."
}
],
"author": [
{
"affiliation": [],
"family": "Abian",
"given": "Olga",
"sequence": "first"
},
{
"affiliation": [],
"family": "Ortega-Alarcon",
"given": "David",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Jimenez-Alesanco",
"given": "Ana",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ceballos-Laita",
"given": "Laura",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Vega",
"given": "Sonia",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Reyburn",
"given": "Hugh T.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Rizzuti",
"given": "Bruno",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Velazquez-Campoy",
"given": "Adrian",
"sequence": "additional"
}
],
"container-title": "International Journal of Biological Macromolecules",
"container-title-short": "International Journal of Biological Macromolecules",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2020,
8,
1
]
],
"date-time": "2020-08-01T01:31:21Z",
"timestamp": 1596245481000
},
"deposited": {
"date-parts": [
[
2024,
12,
18
]
],
"date-time": "2024-12-18T23:01:14Z",
"timestamp": 1734562874000
},
"funder": [
{
"name": "Fundación hna"
},
{
"DOI": "10.13039/501100004587",
"award": [
"CPII13/00017"
],
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/501100004587",
"id-type": "DOI"
}
],
"name": "Instituto de Salud Carlos III"
},
{
"DOI": "10.13039/501100004587",
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/501100004587",
"id-type": "DOI"
}
],
"name": "Instituto de Salud Carlos III"
},
{
"DOI": "10.13039/501100000780",
"award": [
"PI18/00343"
],
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/501100000780",
"id-type": "DOI"
}
],
"name": "European Union"
},
{
"DOI": "10.13039/501100003329",
"award": [
"BFU2016-78232-P",
"SAF2017-83265-R"
],
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/501100003329",
"id-type": "DOI"
}
],
"name": "Ministry of Economy and Competitiveness"
},
{
"DOI": "10.13039/100014440",
"award": [
"BES-2017-080739"
],
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/100014440",
"id-type": "DOI"
}
],
"name": "Ministry of Science, Innovation and Universities"
},
{
"DOI": "10.13039/501100003339",
"award": [
"202020E079"
],
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/501100003339",
"id-type": "DOI"
}
],
"name": "Spanish National Research Council"
},
{
"award": [
"E45_20R",
"B25_20R"
],
"name": "Diputación General de Aragón"
},
{
"name": "Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas"
}
],
"indexed": {
"date-parts": [
[
2025,
6,
25
]
],
"date-time": "2025-06-25T23:06:53Z",
"timestamp": 1750892813917,
"version": "3.37.3"
},
"is-referenced-by-count": 209,
"issued": {
"date-parts": [
[
2020,
12
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
12,
1
]
],
"date-time": "2020-12-01T00:00:00Z",
"timestamp": 1606780800000
}
},
{
"URL": "https://www.elsevier.com/legal/tdmrep-license",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
12,
1
]
],
"date-time": "2020-12-01T00:00:00Z",
"timestamp": 1606780800000
}
},
{
"URL": "https://doi.org/10.15223/policy-017",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
12,
1
]
],
"date-time": "2020-12-01T00:00:00Z",
"timestamp": 1606780800000
}
},
{
"URL": "https://doi.org/10.15223/policy-037",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
12,
1
]
],
"date-time": "2020-12-01T00:00:00Z",
"timestamp": 1606780800000
}
},
{
"URL": "https://doi.org/10.15223/policy-012",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
12,
1
]
],
"date-time": "2020-12-01T00:00:00Z",
"timestamp": 1606780800000
}
},
{
"URL": "https://doi.org/10.15223/policy-029",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
12,
1
]
],
"date-time": "2020-12-01T00:00:00Z",
"timestamp": 1606780800000
}
},
{
"URL": "https://doi.org/10.15223/policy-004",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
12,
1
]
],
"date-time": "2020-12-01T00:00:00Z",
"timestamp": 1606780800000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S0141813020339970?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S0141813020339970?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "1693-1703",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2020,
12
]
]
},
"published-print": {
"date-parts": [
[
2020,
12
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1056/NEJMoa2001017",
"article-title": "A novel coronavirus from patients with pneumonia in China, 2019",
"author": "Zhu",
"doi-asserted-by": "crossref",
"first-page": "727",
"issue": "8",
"journal-title": "N. Engl. J. Med.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0005",
"volume": "382",
"year": "2020"
},
{
"author": "W.H.O. (WHO)",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0010"
},
{
"DOI": "10.1016/S0140-6736(20)30183-5",
"article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
"author": "Huang",
"doi-asserted-by": "crossref",
"first-page": "497",
"issue": "10223",
"journal-title": "Lancet",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0015",
"volume": "395",
"year": "2020"
},
{
"author": "Adams",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0020",
"series-title": "Supporting the Health Care Workforce During the COVID-19 Global Epidemic",
"year": "2020"
},
{
"DOI": "10.1016/j.lfs.2020.117839",
"article-title": "Coronaviruses pathogenesis, comorbidities and multi-organ damage - a review",
"author": "Renu",
"doi-asserted-by": "crossref",
"journal-title": "Life Sci.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0025",
"volume": "255",
"year": "2020"
},
{
"DOI": "10.1038/s41392-020-0191-1",
"article-title": "Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2",
"author": "Catanzaro",
"doi-asserted-by": "crossref",
"first-page": "84",
"issue": "1",
"journal-title": "Signal Transduct. Target. Ther.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0030",
"volume": "5",
"year": "2020"
},
{
"DOI": "10.1111/jebm.12395",
"article-title": "An introduction to economic studies, health emergencies, and COVID-19",
"author": "Clarke",
"doi-asserted-by": "crossref",
"first-page": "161",
"issue": "2",
"journal-title": "J. Evid. Based Med.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0035",
"volume": "13",
"year": "2020"
},
{
"DOI": "10.1111/febs.15375",
"article-title": "A guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2",
"author": "Atzrodt",
"doi-asserted-by": "crossref",
"journal-title": "FEBS J.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0040",
"year": "2020"
},
{
"DOI": "10.1128/AAC.00976-10",
"article-title": "Combinatorial approaches to the prevention and treatment of HIV-1 infection",
"author": "Pirrone",
"doi-asserted-by": "crossref",
"first-page": "1831",
"issue": "5",
"journal-title": "Antimicrob. Agents Chemother.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0045",
"volume": "55",
"year": "2011"
},
{
"DOI": "10.1038/nrd.2018.168",
"article-title": "Drug repurposing: progress, challenges and recommendations",
"author": "Pushpakom",
"doi-asserted-by": "crossref",
"first-page": "41",
"issue": "1",
"journal-title": "Nat. Rev. Drug Discov.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0050",
"volume": "18",
"year": "2019"
},
{
"DOI": "10.1038/s41591-020-0820-9",
"article-title": "The proximal origin of SARS-CoV-2",
"author": "Andersen",
"doi-asserted-by": "crossref",
"first-page": "450",
"issue": "4",
"journal-title": "Nat. Med.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0055",
"volume": "26",
"year": "2020"
},
{
"DOI": "10.1038/s41577-020-0311-8",
"article-title": "The trinity of COVID-19: immunity, inflammation and intervention",
"author": "Tay",
"doi-asserted-by": "crossref",
"first-page": "363",
"issue": "6",
"journal-title": "Nat. Rev. Immunol.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0060",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.3390/jcm9041225",
"article-title": "The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control",
"author": "Helmy",
"doi-asserted-by": "crossref",
"first-page": "1225",
"issue": "4",
"journal-title": "J. Clin. Med.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0065",
"volume": "9",
"year": "2020"
},
{
"DOI": "10.1073/pnas.1835675100",
"article-title": "The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor",
"author": "Yang",
"doi-asserted-by": "crossref",
"issue": "23",
"journal-title": "Proc. Natl. Acad. Sci.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0070",
"volume": "100",
"year": "2003"
},
{
"DOI": "10.1111/febs.12222",
"article-title": "Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins",
"author": "Muramatsu",
"doi-asserted-by": "crossref",
"first-page": "2002",
"issue": "9",
"journal-title": "FEBS J.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0075",
"volume": "280",
"year": "2013"
},
{
"DOI": "10.1016/j.virusres.2015.05.018",
"article-title": "Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus",
"author": "Wu",
"doi-asserted-by": "crossref",
"first-page": "56",
"journal-title": "Virus Res.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0080",
"volume": "208",
"year": "2015"
},
{
"DOI": "10.1002/cbic.202000047",
"article-title": "Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV",
"author": "Morse",
"doi-asserted-by": "crossref",
"first-page": "730",
"issue": "5",
"journal-title": "Chembiochem. Eur. J. Chem. Biol.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0085",
"volume": "21",
"year": "2020"
},
{
"DOI": "10.1021/acs.jmedchem.9b01828",
"article-title": "α-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "4562",
"issue": "9",
"journal-title": "J. Med. Chem.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0090",
"volume": "63",
"year": "2020"
},
{
"article-title": "Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach",
"author": "Khan",
"first-page": "1",
"journal-title": "J. Biomol. Struct. Dyn.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0095",
"year": "2020"
},
{
"DOI": "10.1016/j.bmc.2013.11.041",
"article-title": "Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings",
"author": "Lee",
"doi-asserted-by": "crossref",
"first-page": "167",
"issue": "1",
"journal-title": "Bioorg. Med. Chem.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0100",
"volume": "22",
"year": "2014"
},
{
"DOI": "10.1016/j.bbrc.2004.04.098",
"article-title": "Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate",
"author": "Kuo",
"doi-asserted-by": "crossref",
"first-page": "862",
"issue": "4",
"journal-title": "Biochem. Biophys. Res. Commun.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0105",
"volume": "318",
"year": "2004"
},
{
"DOI": "10.1126/science.abb3405",
"article-title": "Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "409",
"issue": "6489",
"journal-title": "Science",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0110",
"volume": "368",
"year": "2020"
},
{
"DOI": "10.1002/jcc.21334",
"article-title": "AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading",
"author": "Trott",
"doi-asserted-by": "crossref",
"first-page": "455",
"issue": "2",
"journal-title": "J. Comput. Chem.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0115",
"volume": "31",
"year": "2010"
},
{
"DOI": "10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B",
"article-title": "Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function",
"author": "Morris",
"doi-asserted-by": "crossref",
"first-page": "1639",
"issue": "14",
"journal-title": "J. Comput. Chem.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0120",
"volume": "19",
"year": "1998"
},
{
"DOI": "10.1186/1758-2946-4-17",
"article-title": "Avogadro: an advanced semantic chemical editor, visualization, and analysis platform",
"author": "Hanwell",
"doi-asserted-by": "crossref",
"first-page": "17",
"issue": "1",
"journal-title": "J. Cheminform.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0125",
"volume": "4",
"year": "2012"
},
{
"DOI": "10.3390/molecules23040894",
"article-title": "Identification by molecular docking of homoisoflavones from Leopoldia comosa as ligands of estrogen receptors",
"author": "Grande",
"doi-asserted-by": "crossref",
"issue": "4",
"journal-title": "Molecules",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0130",
"volume": "23",
"year": "2018"
},
{
"DOI": "10.1007/s13238-010-0044-8",
"article-title": "Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "371",
"issue": "4",
"journal-title": "Protein Cell",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0135",
"volume": "1",
"year": "2010"
},
{
"DOI": "10.1007/978-1-59745-367-7_3",
"article-title": "Defining the stability of multimeric proteins",
"author": "Shriver",
"doi-asserted-by": "crossref",
"first-page": "57",
"journal-title": "Methods Mol. Biol.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0140",
"volume": "490",
"year": "2009"
},
{
"DOI": "10.1016/S0006-3495(92)81899-4",
"article-title": "Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry",
"author": "Sanchez-Ruiz",
"doi-asserted-by": "crossref",
"first-page": "921",
"issue": "4",
"journal-title": "Biophys. J.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0145",
"volume": "61",
"year": "1992"
},
{
"DOI": "10.1021/bi0361766",
"article-title": "Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro",
"author": "Bacha",
"doi-asserted-by": "crossref",
"first-page": "4906",
"issue": "17",
"journal-title": "Biochemistry",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0150",
"volume": "43",
"year": "2004"
},
{
"DOI": "10.1016/j.ab.2006.07.027",
"article-title": "Thermofluor-based high-throughput stability optimization of proteins for structural studies",
"author": "Ericsson",
"doi-asserted-by": "crossref",
"first-page": "289",
"journal-title": "Anal. Biochem.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0155",
"year": "2006"
},
{
"DOI": "10.1177/108705710100600609",
"article-title": "High-density miniaturized thermal shift assays as a general strategy for drug discovery",
"author": "Pantoliano",
"doi-asserted-by": "crossref",
"first-page": "429",
"issue": "6",
"journal-title": "J. Biomol. Screen.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0160",
"volume": "6",
"year": "2001"
},
{
"DOI": "10.1529/biophysj.108.134973",
"article-title": "A quantitative model of thermal stabilization and destabilization of proteins by ligands",
"author": "Cimmperman",
"doi-asserted-by": "crossref",
"first-page": "3222",
"issue": "7",
"journal-title": "Biophys. J.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0165",
"volume": "95",
"year": "2008"
},
{
"DOI": "10.3390/microorganisms8040503",
"article-title": "Small molecule inhibitors of the response regulator ArsR exhibit bactericidal activity against Helicobacter pylori",
"author": "González",
"doi-asserted-by": "crossref",
"issue": "4",
"journal-title": "Microorganisms",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0170",
"volume": "8",
"year": "2020"
},
{
"DOI": "10.1089/ars.2018.7658",
"article-title": "Redox- and ligand binding-dependent conformational ensembles in the human apoptosis-inducing factor regulate its pro-life and cell death functions",
"author": "Villanueva",
"doi-asserted-by": "crossref",
"first-page": "2013",
"issue": "18",
"journal-title": "Antioxid. Redox Signal.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0175",
"volume": "30",
"year": "2019"
},
{
"DOI": "10.1021/ac00217a020",
"article-title": "Resolution of multicomponent fluorescence emission using frequency-dependent phase angle and modulation spectra",
"author": "Lakowicz",
"doi-asserted-by": "crossref",
"first-page": "2005",
"issue": "18",
"journal-title": "Anal. Chem.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0180",
"volume": "62",
"year": "1990"
},
{
"DOI": "10.1016/S0079-6468(08)70097-3",
"article-title": "Isothermal titration calorimetry in drug discovery",
"author": "Ward",
"doi-asserted-by": "crossref",
"first-page": "309",
"journal-title": "Prog. Med. Chem.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0185",
"year": "2001"
},
{
"DOI": "10.1080/17460441.2017.1297418",
"article-title": "A look at ligand binding thermodynamics in drug discovery",
"author": "Claveria-Gimeno",
"doi-asserted-by": "crossref",
"first-page": "363",
"issue": "4",
"journal-title": "Expert. Opin. Drug Discov.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0190",
"volume": "12",
"year": "2017"
},
{
"DOI": "10.1038/s41598-019-47746-9",
"article-title": "Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA",
"author": "González",
"doi-asserted-by": "crossref",
"issue": "1",
"journal-title": "Sci. Rep.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0195",
"volume": "9",
"year": "2019"
},
{
"article-title": "Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis",
"author": "Santofimia-Castano",
"first-page": "130",
"journal-title": "J. Clin. Invest.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0200",
"year": "2019"
},
{
"DOI": "10.1038/srep39732",
"article-title": "Identification of a drug targeting an intrinsically disordered protein involved in pancreatic adenocarcinoma",
"author": "Neira",
"doi-asserted-by": "crossref",
"journal-title": "Sci. Rep.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0205",
"volume": "7",
"year": "2017"
},
{
"DOI": "10.1371/journal.pone.0159002",
"article-title": "Inhibition of pig phosphoenolpyruvate carboxykinase isoenzymes by 3-mercaptopicolinic acid and novel inhibitors",
"author": "Hidalgo",
"doi-asserted-by": "crossref",
"issue": "7",
"journal-title": "PLoS One",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0210",
"volume": "11",
"year": "2016"
},
{
"DOI": "10.1371/journal.pone.0069773",
"article-title": "Allosteric inhibitors of the NS3 protease from the hepatitis C virus",
"author": "Abian",
"doi-asserted-by": "crossref",
"issue": "7",
"journal-title": "PLoS One",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0215",
"volume": "8",
"year": "2013"
},
{
"DOI": "10.1172/JCI34355",
"article-title": "Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria",
"author": "Pey",
"doi-asserted-by": "crossref",
"first-page": "2858",
"issue": "8",
"journal-title": "J. Clin. Invest.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0220",
"volume": "118",
"year": "2008"
},
{
"DOI": "10.1021/cb900166q",
"article-title": "Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection",
"author": "Cremades",
"doi-asserted-by": "crossref",
"first-page": "928",
"issue": "11",
"journal-title": "ACS Chem. Biol.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0225",
"volume": "4",
"year": "2009"
},
{
"DOI": "10.1074/jbc.M311744200",
"article-title": "Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors",
"author": "Shi",
"doi-asserted-by": "crossref",
"first-page": "24765",
"issue": "23",
"journal-title": "J. Biol. Chem.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0230",
"volume": "279",
"year": "2004"
},
{
"DOI": "10.1038/s41467-019-13686-1",
"article-title": "Engineering protein assemblies with allosteric control via monomer fold-switching",
"author": "Campos",
"doi-asserted-by": "crossref",
"first-page": "5703",
"issue": "1",
"journal-title": "Nat. Commun.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0235",
"volume": "10",
"year": "2019"
},
{
"DOI": "10.1006/jmbi.1997.1613",
"article-title": "The conformational equilibrium of human growth hormone",
"author": "Kasimova",
"doi-asserted-by": "crossref",
"first-page": "409",
"journal-title": "J Mol Biol",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0240",
"volume": "1998",
"year": "1998"
},
{
"DOI": "10.2174/1389450117666160201110449",
"article-title": "Biophysical screening for identifying pharmacological chaperones and inhibitors against conformational and infectious diseases",
"author": "Velazquez-Campoy",
"doi-asserted-by": "crossref",
"first-page": "1492",
"issue": "13",
"journal-title": "Curr. Drug Targets",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0245",
"volume": "17",
"year": "2016"
},
{
"DOI": "10.1016/S1359-6446(05)03386-6",
"article-title": "Ligand efficiency indices as guideposts for drug discovery",
"author": "Abad-Zapatero",
"doi-asserted-by": "crossref",
"first-page": "464",
"journal-title": "Drug Discov. Today",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0250",
"year": "2005"
},
{
"DOI": "10.1111/cbdd.13604",
"article-title": "Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors",
"author": "Jo",
"doi-asserted-by": "crossref",
"first-page": "2023",
"issue": "6",
"journal-title": "Chem. Biol. Drug Des.",
"key": "10.1016/j.ijbiomac.2020.07.235_bb0255",
"volume": "94",
"year": "2019"
}
],
"reference-count": 51,
"references-count": 51,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S0141813020339970"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"special_numbering": "C",
"subject": [],
"subtitle": [],
"title": "Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening",
"type": "journal-article",
"update-policy": "https://doi.org/10.1016/elsevier_cm_policy",
"volume": "164"
}
